You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API desonide


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing desonide

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Intendis Inc DESONATE desonide 10922-828 EDETATE DISODIUM
Intendis Inc DESONATE desonide 10922-828 GLYCERIN
Intendis Inc DESONATE desonide 10922-828 METHYLPARABEN
Intendis Inc DESONATE desonide 10922-828 PROPYLENE GLYCOL
Intendis Inc DESONATE desonide 10922-828 PROPYLPARABEN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing desonide

Company Ingredient NDC Excipient
Amneal Pharmaceuticals of New York LLC desonide 0115-1517 ANHYDROUS CITRIC ACID
Amneal Pharmaceuticals of New York LLC desonide 0115-1517 CETYL ALCOHOL
Amneal Pharmaceuticals of New York LLC desonide 0115-1517 EDETATE SODIUM
Amneal Pharmaceuticals of New York LLC desonide 0115-1517 GLYCERYL STEARATE SE
Amneal Pharmaceuticals of New York LLC desonide 0115-1517 LIGHT MINERAL OIL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for desonide

Excipient focus: ALUMINUM SUBACETATE

Excipient focus: ALUMINUM SULFATE

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: CALCIUM ACETATE

Excipient focus: CARBOMER HOMOPOLYMER TYPE A

desonide drug variants not containing CARBOMER HOMOPOLYMER TYPE A

Company Ingredient NDC
Amneal Pharmaceuticals of New York LLC desonide 0115-1517
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0168-0309
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0168-0310
Galderma Laboratories LP desonide 0299-5770
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0462-0392
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

desonide drug variants not containing CARBOMER HOMOPOLYMER TYPE B

Company Ingredient NDC
Amneal Pharmaceuticals of New York LLC desonide 0115-1517
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0168-0309
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0168-0310
Galderma Laboratories LP desonide 0299-5770
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0462-0392
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: CETOSTEARYL ALCOHOL

Excipient focus: CETYL ALCOHOL

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CYCLOMETHICONE

Excipient focus: DIETHYLENE GLYCOL MONOETHYL ETHER

desonide drug variants not containing DIETHYLENE GLYCOL MONOETHYL ETHER

Company Ingredient NDC
Amneal Pharmaceuticals of New York LLC desonide 0115-1517
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0168-0309
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0168-0310
Galderma Laboratories LP desonide 0299-5770
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0462-0392
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: EDETATE DISODIUM

Excipient focus: EDETATE SODIUM

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: GLYCERYL STEARATE SE

Excipient focus: ICODEXTRIN

Excipient focus: ISOPROPYL MYRISTATE

Excipient focus: ISOPROPYL PALMITATE

Excipient focus: LIGHT MINERAL OIL

Excipient focus: METHYLPARABEN

Excipient focus: MINERAL OIL

Excipient focus: PETROLATUM

Excipient focus: PHENOXYETHANOL

Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER

desonide drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER

Company Ingredient NDC
Amneal Pharmaceuticals of New York LLC desonide 0115-1517
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0168-0309
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0168-0310
Galderma Laboratories LP desonide 0299-5770
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0462-0392
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYSORBATE 60

Excipient focus: POTASSIUM CITRATE

Excipient focus: POTASSIUM SORBATE

Excipient focus: PROPYL GALLATE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SODIUM CETOSTEARYL SULFATE

desonide drug variants not containing SODIUM CETOSTEARYL SULFATE

Company Ingredient NDC
Amneal Pharmaceuticals of New York LLC desonide 0115-1517
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0168-0309
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0168-0310
Galderma Laboratories LP desonide 0299-5770
E Fougera & Co a division of Fougera Pharmaceuticals Inc desonide 0462-0392
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SORBIC ACID

Excipient focus: SORBITAN MONOLAURATE

Excipient focus: SORBITAN MONOSTEARATE

Excipient focus: STEARIC ACID

Excipient focus: STEARYL ALCOHOL

Excipient focus: SYNTHETIC WAX

Excipient focus: WATER

Excipient focus: WHITE WAX

Excipient focus: YELLOW WAX

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links